Canine osteosarcoma (OSA) is an aggressive bone tumor in dogs. Standard-of-care treatment typically results in relatively short survival times; thus, alternative treatments are needed to confer a survival advantage. It has been shown that OSA is an immunogenic tumor, suggesting that immune